7oh Tablets

Updated June 24, 2026

Overview

Supplier sourcing insights & recommendations

U.S. Food and Drug Administration (.gov)

International Society of Substance Use Professionals (ISSUP)

29 来源

The 7-OH (7-hydroxymitragynine) tablet market in 2026 is characterized by rapid growth alongside intense regulatory pressure. Estimated to have over 1 million monthly users, the market is currently a high-margin but high-risk "gray market" due to increasing FDA crackdowns and state-level bans Nutraingredients Inquirer.

Market Trends & Insights

* Regulatory Crackdown: The FDA has declared 7-OH an unlawful dietary supplement and unapproved drug, leading to warning letters and $1 million+ in product seizures as of late 2025 Fda Nutraingredients.

* Pricing Dynamics: Retail prices vary significantly by brand, with Kream averaging $0.08/mg and Press'd reaching $0.19/mg 7Oh.

* Consumer Behavior: Users prioritize scored tablets for dose splitting and look for lab-verified COAs (Certificates of Analysis) due to concerns over synthetic additives 7Oh Thecalmleaf.

* Product Evolution: Manufacturers are frequently "tweaking" formulas to bypass pending state bans in regions like Pennsylvania and New Jersey Inquirer.

Supplier Identification

Sourcing 7-OH tablets directly through standard B2B platforms is challenging due to the specialized nature and regulatory status of the alkaloid. However, several botanical and pharmaceutical manufacturers provide private-label services for concentrated herbal extract tablets.

I have compiled a list of 10+ manufacturers specializing in plant extract and herbal supplement tablets who have the R&D capacity to handle complex botanical formulations. Please refer to the attached supplier list for detailed company profiles, certifications, and product offerings.

Explore the latest 7-OH market trends and sourcing options with these next steps: